Evidence map›Paper›PMID 41311869›Full record

ArticlebioRxiv : the preprint server for biology2025

Systematic characterization of existing and novel inducible transgenic systems in human pluripotent stem cells after prolonged differentiation.

Michael D Gallagher, Andrew S Khalil, Qi Liu, Tenzin Lungjangwa, Antar Drews, Blake F Hanan, Moritz List, Henry Hardart, David J Mooney, Rudolf Jaenisch

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael D GallagherWhitehead Institute for Biomedical Research, Cambridge, MA, USA.ORCID 0000-0002-2109-1293
Andrew S KhalilWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Qi LiuWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Tenzin LungjangwaWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Antar DrewsWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Blake F HananJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Moritz ListWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Henry HardartWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
David J MooneyJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Rudolf JaenischWhitehead Institute for Biomedical Research, Cambridge, MA, USA.

Funding

Epigenomic, transcriptional and cellular dissection of Alzheimer's variantsR01AG058002 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HYMAN, BRADLEY T., JAENISCH, RUDOLF · 2017 to 2021
$7.9M
Organ Design and Engineering Training Program (ODET Program)T32EB016652 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2014 to 2023
$3.5M
Human induced pluripotent stem cell modeling of genetic risk factors for Alzheimer's diseaseF32AG060695 · NIA · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI GALLAGHER, MICHAEL D · 2018 to 2021
$197k
NIA NIH HHS F32 AG060695NIA NIH HHS R01 AG058002NIBIB NIH HHS T32 EB016652Wellcome Trust
6 · The paper itself

Abstract

The ability to control transgene expression both temporally and quantitatively in human-relevant cells and tissues is a cornerstone of biomedical research. Additionally, precise transgene control is crucial for optimizing human cell-based gene therapies. Human pluripotent stem cells (hPSCs) have facilitated major advances in disease modeling and the potential for regenerative medicine. Still, they are significantly limited by the lack of inducible transgenic systems that avoid silencing but maintain robust inducibility after differentiation to defined cell lineages. Here we systematically characterize the leakiness, inducibility, and tunability of multiple existing and novel transgenic systems in hPSCs and differentiated macrophages and microglia. Notably, we report the application of a small molecule-mediated splicing switch (X

Identifiers

PMID41311869
PMCPMC12653992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.